ID

29748

Beskrivning

https://clinicaltrials.gov/show/NCT00197028 Sample Case Report Form Study ID: 103967 Clinical Study ID: 103967 Study Title: A Phase I/IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00197028 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: BIO MALARIA; SB257049 Study Indication: Malaria

Länk

https://clinicaltrials.gov/show/NCT00197028

Nyckelord

  1. 2018-04-18 2018-04-18 -
Rättsinnehavare

GlaxoSmithKline (GSK)

Uppladdad den

18 april 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region, Study ID: 103967, NCT00197028

Sample Case Report Form: Laboratory Reference Ranges and Serious Adverse Events

Laboratory Reference Ranges
Beskrivning

Laboratory Reference Ranges

Alias
UMLS CUI-1
C0883335
Laboratory Name
Beskrivning

Laboratory Name

Datatyp

text

Alias
UMLS CUI [1]
C1882331
Lab Code
Beskrivning

Laboratory Code

Datatyp

integer

Alias
UMLS CUI [1,1]
C0022877
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C0600091
Reference Range
Beskrivning

Reference Range

Alias
UMLS CUI-1
C0883335
Date these reference ranges became effective:
Beskrivning

Date of reference range

Datatyp

date

Alias
UMLS CUI [1,1]
C0883335
UMLS CUI [1,2]
C0011008
Age range: low - high
Beskrivning

Age range

Datatyp

integer

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C1514721
Age units (tick one box)
Beskrivning

Age units

Datatyp

integer

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0001779
Sex
Beskrivning

Sex

Datatyp

integer

Alias
UMLS CUI [1]
C0079399
Lab test: Biochemistry and Haematology
Beskrivning

Laboratory Test

Datatyp

integer

Alias
UMLS CUI [1]
C0022885
Unit
Beskrivning

Laboratory test unit

Datatyp

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0439148
Low Reference Value
Beskrivning

Low Reference Value

Datatyp

float

Alias
UMLS CUI [1,1]
C0587081
UMLS CUI [1,2]
C1522609
UMLS CUI [1,3]
C0205251
High Reference value
Beskrivning

High Reference value

Datatyp

float

Alias
UMLS CUI [1,1]
C0587081
UMLS CUI [1,2]
C1522609
UMLS CUI [1,3]
C0205250
Serious adverse events
Beskrivning

Serious adverse events

Alias
UMLS CUI-1
C1519255
Center number
Beskrivning

Center number

Datatyp

integer

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Country
Beskrivning

Country

Datatyp

text

Alias
UMLS CUI [1]
C0454664
GSK Receipt Date
Beskrivning

GSK Receipt Date

Datatyp

date

Alias
UMLS CUI [1]
C2985846
Subject Number
Beskrivning

Subject Number

Datatyp

integer

Alias
UMLS CUI [1]
C2348585
Type of information
Beskrivning

Type of information

Datatyp

integer

Alias
UMLS CUI [1]
C1508263
SAE N°
Beskrivning

Serious adverse event number

Datatyp

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0237753
Section 1
Beskrivning

Section 1

Alias
UMLS CUI-1
C1519255
UMLS CUI-2
C1828479
Diagnosis only (if known), otherwise sign / symptom
Beskrivning

Event

Datatyp

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0011900
Start date
Beskrivning

Start date

Datatyp

date

Alias
UMLS CUI [1]
C2697888
Outcome
Beskrivning

Outcome

Datatyp

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1519255
End date
Beskrivning

If fatal, record date of death

Datatyp

date

Alias
UMLS CUI [1]
C2697886
Maximum intensity
Beskrivning

Maximum intensity

Datatyp

integer

Alias
UMLS CUI [1]
C1710066
Action taken with investigational product(s) as a result of the SAE
Beskrivning

Action taken with investigational product(s)

Datatyp

integer

Alias
UMLS CUI [1,1]
C1704758
UMLS CUI [1,2]
C1519255
Did the subject withdraw from study as a result of this SAE? (*)
Beskrivning

(*) If yes, please complete the Study Conclusion page in the CRF of the subject and tick SAE as reason for withdrawal

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
Is there a reasonable possibility that the SAE may have been caused by the investigational product?
Beskrivning

Relationship to investigational product(s)

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0085978
UMLS CUI [1,3]
C1519255
Medically attended visit?
Beskrivning

HO:Hospitalisation ER:Emergency Room MD:Medical Doctor Refer to protocol for full definition

Datatyp

integer

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C1386497
UMLS CUI [1,3]
C1519255
Was a post-mortem / autopsy performed?
Beskrivning

If yes, summarize findings in narrative remarks section of this SAE form.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0004398
UMLS CUI [1,2]
C1519255
Section 2
Beskrivning

Section 2

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C1710056
Seriousness, specify reason(s) for considering this a SAE, tick all that apply):
Beskrivning

Seriousness

Datatyp

integer

Alias
UMLS CUI [1,1]
C1710056
UMLS CUI [1,2]
C1519255
Section 3 - Demography Data
Beskrivning

Section 3 - Demography Data

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C0011298
Date of birth:
Beskrivning

Date of birth

Datatyp

date

Alias
UMLS CUI [1]
C0421451
Sex
Beskrivning

Sex

Datatyp

integer

Alias
UMLS CUI [1]
C0079399
Weight
Beskrivning

Weight

Datatyp

float

Måttenheter
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Weight (US only)
Beskrivning

Weight

Datatyp

integer

Måttenheter
  • pounds/ounces
Alias
UMLS CUI [1]
C0005910
pounds/ounces
Section 4
Beskrivning

Section 4

Alias
UMLS CUI-1
C1828479
If investigational product was stopped, did the reported event(s) recur after further investigational product(s) were administered?
Beskrivning

Recurrence of reported event

Datatyp

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0034897
Section 5 - Causes of SAE
Beskrivning

Section 5 - Causes of SAE

Alias
UMLS CUI-1
C1519255
UMLS CUI-2
C0085978
Possible causes of SAE other than investigational product: (tick all that apply)
Beskrivning

Causes of SAE

Datatyp

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0085978
Section 6 – Relevant Medical Conditions
Beskrivning

Section 6 – Relevant Medical Conditions

Alias
UMLS CUI-1
C0012634
UMLS CUI-2
C0262926
UMLS CUI-3
C1519255
Specify any relevant past or current medical disorders, allergies, surgeries, etc., that can help explain the SAE
Beskrivning

Medical disorders

Datatyp

text

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2]
C0020517
UMLS CUI [3]
C0543467
Date of onset
Beskrivning

Date of onset

Datatyp

date

Alias
UMLS CUI [1,1]
C0574845
UMLS CUI [1,2]
C0012634
Condition present at time of SAE?
Beskrivning

Present condition

Datatyp

boolean

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2]
C1519255
If no, date of last occurrence
Beskrivning

Date of last occurence

Datatyp

date

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C2745955
Section 7 - Other relevant risk factors
Beskrivning

Section 7 - Other relevant risk factors

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C0035648
Other relevant risk factors: (specify any family or social history (smoking, diet, drug abuse, occupational hazard) relevant to the SAE):
Beskrivning

Other relevant risk factors

Datatyp

text

Alias
UMLS CUI [1,1]
C0035648
UMLS CUI [1,2]
C1519255
Section 8 – Relevant Concomitant Medications
Beskrivning

Section 8 – Relevant Concomitant Medications

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C2347852
Drug Name (Trade name preferred)
Beskrivning

Drug name

Datatyp

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C2347852
Dose
Beskrivning

Dose

Datatyp

integer

Alias
UMLS CUI [1]
C3174092
Unit
Beskrivning

Unit

Datatyp

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C2347852
Frequency
Beskrivning

Frequency

Datatyp

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C2347852
Route
Beskrivning

Route

Datatyp

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C2347852
Taken prior to study?
Beskrivning

Concomitant Medications

Datatyp

boolean

Alias
UMLS CUI [1]
C2347852
Date started
Beskrivning

Date started

Datatyp

date

Alias
UMLS CUI [1]
C2826734
Date stopped
Beskrivning

Date stopped

Datatyp

date

Alias
UMLS CUI [1]
C2826744
Ongoing?
Beskrivning

Ongoing

Datatyp

boolean

Alias
UMLS CUI [1]
C2826666
Reason for medication
Beskrivning

Reason for medication

Datatyp

text

Alias
UMLS CUI [1]
C2826696
Section 9 – Details of investigational product(s)
Beskrivning

Section 9 – Details of investigational product(s)

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C0013230
UMLS CUI-3
C1522508
Vaccine (specify mixed or separate)
Beskrivning

Vaccine

Datatyp

text

Alias
UMLS CUI [1]
C0042210
Dose N°
Beskrivning

Dose number

Datatyp

integer

Alias
UMLS CUI [1,1]
C1115464
UMLS CUI [1,2]
C0042210
Lot N°
Beskrivning

Lot number

Datatyp

integer

Alias
UMLS CUI [1,1]
C2826710
UMLS CUI [1,2]
C0042210
Route / site
Beskrivning

Route / site

Datatyp

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
UMLS CUI [2]
C1515974
Date
Beskrivning

Administration date

Datatyp

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0042210
Was randomization code broken at investigational site?
Beskrivning

Randomization code

Datatyp

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0443289
Section 10 – Details of relevant assessments
Beskrivning

Section 10 – Details of relevant assessments

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C0220825
Details of relevant assessments: (provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE, e.g. laboratory data with units and normal range)
Beskrivning

Details of relevant assessments

Datatyp

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C1261322
UMLS CUI [1,3]
C1522508
Section 11 – Narrative remarks
Beskrivning

Section 11 – Narrative remarks

Alias
UMLS CUI-1
C1828479
UMLS CUI-2
C0947611
Narrative remarks: (provide a brief narrative description of the SAE and details of treatment given):
Beskrivning

Narrative remarks

Datatyp

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C1519255
Section 12 – SAE additional / follow-up information
Beskrivning

Section 12 – SAE additional / follow-up information

Alias
UMLS CUI-1
C1524062
UMLS CUI-2
C1533716
UMLS CUI-3
C1519255
UMLS CUI-4
C1522577
SAE additional / follow-up information (use this page to provide any additional details on the SAE not already captured on the previous pages):
Beskrivning

SAE additional / follow-up information

Datatyp

text

Alias
UMLS CUI [1,1]
C1524062
UMLS CUI [1,2]
C1533716
UMLS CUI [1,3]
C1519255
UMLS CUI [1,4]
C1522577
Administative data
Beskrivning

Administative data

Alias
UMLS CUI-1
C1320722
Investigator’s signature:
Beskrivning

Investigator’s signature

Datatyp

text

Alias
UMLS CUI [1]
C2346576
Date
Beskrivning

Date

Datatyp

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Please PRINT name:
Beskrivning

Printed name

Datatyp

text

Alias
UMLS CUI [1]
C2826892

Similar models

Sample Case Report Form: Laboratory Reference Ranges and Serious Adverse Events

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Laboratory Reference Ranges
C0883335 (UMLS CUI-1)
Laboratory Name
Item
Laboratory Name
text
C1882331 (UMLS CUI [1])
Laboratory Code
Item
Lab Code
integer
C0022877 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
Item Group
Reference Range
C0883335 (UMLS CUI-1)
Date of reference range
Item
Date these reference ranges became effective:
date
C0883335 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Age range
Item
Age range: low - high
integer
C0001779 (UMLS CUI [1,1])
C1514721 (UMLS CUI [1,2])
Item
Age units (tick one box)
integer
C1519795 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
Code List
Age units (tick one box)
CL Item
years (1)
CL Item
months (2)
CL Item
weeks (3)
CL Item
days (4)
Item
Sex
integer
C0079399 (UMLS CUI [1])
Code List
Sex
CL Item
Male reference range (1)
CL Item
Female reference range (2)
CL Item
Male and Female reference range (3)
Item
Lab test: Biochemistry and Haematology
integer
C0022885 (UMLS CUI [1])
Code List
Lab test: Biochemistry and Haematology
CL Item
ALT (1)
CL Item
Creatinine (2)
CL Item
Bilirubin (3)
CL Item
Haemoglobin (4)
CL Item
WBC (White blood cells) total: (5)
CL Item
PCV (Packed cell volume)/ Haematocrit (6)
CL Item
Platelets (7)
Laboratory test unit
Item
Unit
text
C0022885 (UMLS CUI [1,1])
C0439148 (UMLS CUI [1,2])
Low Reference Value
Item
Low Reference Value
float
C0587081 (UMLS CUI [1,1])
C1522609 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,3])
High Reference value
Item
High Reference value
float
C0587081 (UMLS CUI [1,1])
C1522609 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,3])
Item Group
Serious adverse events
C1519255 (UMLS CUI-1)
Center number
Item
Center number
integer
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Country
Item
Country
text
C0454664 (UMLS CUI [1])
GSK Receipt Date
Item
GSK Receipt Date
date
C2985846 (UMLS CUI [1])
Subject Number
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item
Type of information
integer
C1508263 (UMLS CUI [1])
Code List
Type of information
CL Item
Initial report (1)
CL Item
Additional information (2)
CL Item
Additional information (3)
CL Item
Additional information (4)
Serious adverse event number
Item
SAE N°
integer
C1519255 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item Group
Section 1
C1519255 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
Event
Item
Diagnosis only (if known), otherwise sign / symptom
text
C1519255 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Start date
Item
Start date
date
C2697888 (UMLS CUI [1])
Item
Outcome
integer
C1705586 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Code List
Outcome
CL Item
1: Recovered/ Resolved (1)
CL Item
2: Recovering / Resolving (2)
CL Item
3: Not recovered/ Not resolved (3)
CL Item
4: Recovered/ Resolved with sequelae (4)
CL Item
5: Fatal (5)
End date
Item
End date
date
C2697886 (UMLS CUI [1])
Item
Maximum intensity
integer
C1710066 (UMLS CUI [1])
Code List
Maximum intensity
CL Item
1: Mild (1)
CL Item
2: Moderate (2)
CL Item
3: Severe (3)
CL Item
X:Not applicable (4)
Item
Action taken with investigational product(s) as a result of the SAE
integer
C1704758 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Code List
Action taken with investigational product(s) as a result of the SAE
CL Item
1: Investigational product(s) withdrawn (1)
CL Item
2: Dose not changed (2)
CL Item
3: Dose Interrupted (3)
CL Item
X:Not applicable (4)
Withdrawal
Item
Did the subject withdraw from study as a result of this SAE? (*)
boolean
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Relationship to investigational product(s)
Item
Is there a reasonable possibility that the SAE may have been caused by the investigational product?
boolean
C0304229 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item
Medically attended visit?
integer
C0545082 (UMLS CUI [1,1])
C1386497 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Code List
Medically attended visit?
CL Item
[HO] (1)
CL Item
[ER] (2)
CL Item
[MD] (3)
Autopsy
Item
Was a post-mortem / autopsy performed?
boolean
C0004398 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Section 2
C1828479 (UMLS CUI-1)
C1710056 (UMLS CUI-2)
Item
Seriousness, specify reason(s) for considering this a SAE, tick all that apply):
integer
C1710056 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Code List
Seriousness, specify reason(s) for considering this a SAE, tick all that apply):
CL Item
Results in death (1)
CL Item
Results in disability / incapacity (2)
CL Item
Is life threatening (3)
CL Item
Congenital anomaly / birth defect in the offspring (4)
CL Item
Requires hospitalisation or prolongation of existing hospitalisation (5)
CL Item
Other, specify: ___________________________________________________ (6)
CL Item
___________________________________________________ (7)
Item Group
Section 3 - Demography Data
C1828479 (UMLS CUI-1)
C0011298 (UMLS CUI-2)
Date of birth
Item
Date of birth:
date
C0421451 (UMLS CUI [1])
Item
Sex
integer
C0079399 (UMLS CUI [1])
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Weight
Item
Weight (US only)
integer
C0005910 (UMLS CUI [1])
Item Group
Section 4
C1828479 (UMLS CUI-1)
Item
If investigational product was stopped, did the reported event(s) recur after further investigational product(s) were administered?
integer
C0877248 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
Code List
If investigational product was stopped, did the reported event(s) recur after further investigational product(s) were administered?
CL Item
No (1)
CL Item
Yes (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Section 5 - Causes of SAE
C1519255 (UMLS CUI-1)
C0085978 (UMLS CUI-2)
Item
Possible causes of SAE other than investigational product: (tick all that apply)
integer
C1519255 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
Code List
Possible causes of SAE other than investigational product: (tick all that apply)
CL Item
Disease under study (1)
CL Item
Concomitant medication (record in Section 8) (2)
CL Item
Medical condition(s) (record in Section 6) (3)
CL Item
Activity related to study participation (e.g. procedures) (4)
CL Item
Lack of efficacy (5)
CL Item
Withdrawal of investigational product (6)
CL Item
Other, specify: ____________________________________________________ (7)
CL Item
____________________________________________________ (8)
Item Group
Section 6 – Relevant Medical Conditions
C0012634 (UMLS CUI-1)
C0262926 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
Medical disorders
Item
Specify any relevant past or current medical disorders, allergies, surgeries, etc., that can help explain the SAE
text
C0012634 (UMLS CUI [1])
C0020517 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Date of onset
Item
Date of onset
date
C0574845 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Present condition
Item
Condition present at time of SAE?
boolean
C0012634 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
Date of last occurence
Item
If no, date of last occurrence
date
C0012634 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
Item Group
Section 7 - Other relevant risk factors
C1828479 (UMLS CUI-1)
C0035648 (UMLS CUI-2)
Other relevant risk factors
Item
Other relevant risk factors: (specify any family or social history (smoking, diet, drug abuse, occupational hazard) relevant to the SAE):
text
C0035648 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Section 8 – Relevant Concomitant Medications
C1828479 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Drug name
Item
Drug Name (Trade name preferred)
text
C2360065 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Dose
Item
Dose
integer
C3174092 (UMLS CUI [1])
Unit
Item
Unit
text
C1519795 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Route
Item
Route
text
C0013153 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Concomitant Medications
Item
Taken prior to study?
boolean
C2347852 (UMLS CUI [1])
Date started
Item
Date started
date
C2826734 (UMLS CUI [1])
Date stopped
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Ongoing
Item
Ongoing?
boolean
C2826666 (UMLS CUI [1])
Reason for medication
Item
Reason for medication
text
C2826696 (UMLS CUI [1])
Item Group
Section 9 – Details of investigational product(s)
C1828479 (UMLS CUI-1)
C0013230 (UMLS CUI-2)
C1522508 (UMLS CUI-3)
Vaccine
Item
Vaccine (specify mixed or separate)
text
C0042210 (UMLS CUI [1])
Dose number
Item
Dose N°
integer
C1115464 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Lot number
Item
Lot N°
integer
C2826710 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Route / site
Item
Route / site
text
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1515974 (UMLS CUI [2])
Administration date
Item
Date
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Item
Was randomization code broken at investigational site?
integer
C0034656 (UMLS CUI [1,1])
C0443289 (UMLS CUI [1,2])
Code List
Was randomization code broken at investigational site?
CL Item
No (1)
CL Item
Yes (2)
CL Item
Not applicable (3)
Item Group
Section 10 – Details of relevant assessments
C1828479 (UMLS CUI-1)
C0220825 (UMLS CUI-2)
Details of relevant assessments
Item
Details of relevant assessments: (provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE, e.g. laboratory data with units and normal range)
text
C1519255 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
C1522508 (UMLS CUI [1,3])
Item Group
Section 11 – Narrative remarks
C1828479 (UMLS CUI-1)
C0947611 (UMLS CUI-2)
Narrative remarks
Item
Narrative remarks: (provide a brief narrative description of the SAE and details of treatment given):
text
C0947611 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Section 12 – SAE additional / follow-up information
C1524062 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C1522577 (UMLS CUI-4)
SAE additional / follow-up information
Item
SAE additional / follow-up information (use this page to provide any additional details on the SAE not already captured on the previous pages):
text
C1524062 (UMLS CUI [1,1])
C1533716 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1522577 (UMLS CUI [1,4])
Item Group
Administative data
C1320722 (UMLS CUI-1)
Investigator’s signature
Item
Investigator’s signature:
text
C2346576 (UMLS CUI [1])
Date
Item
Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Printed name
Item
Please PRINT name:
text
C2826892 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial